Daily oral PrEP (generic Truvada; Descovy) is effective but adherence-sensitive, and seroconversions in trials correlate with ...

In this interview, Luis Ortiz, M.D., explains the current and emerging therapies for narcolepsy type 1 treatment. Narcolepsy ...

CVS Caremark’s preferred-formulary shift from tirzepatide to semaglutide produced a 17-fold jump in tirzepatide switching ...

Cancer therapeutics and orphan drugs are no longer niche areas. Specialty drugs are now a significant portion of the prescription drug market, as well as the drug development pipeline, according to a ...

The burden of living with narcolepsy is high, and it starts at a young age, according to Luis Ortiz, M.D., assistant ...

Julie Kendle, Pharm.D., senior director of clinical pharmacy at IPD Analytics, explains how managed care organizations can ...

The Maximum Fair Price (MFP), established by the Inflation Reduction Act, allows CMS to negotiate prices for Medicare drugs.

CAR-T cell therapy has spread into earlier lines of care over the last ten years, going beyond heavily pretreated populations ...

Obesity therapeutics now represent ~$98B and 4.6% share, climbing to the fourth-largest category, with ~190 pipeline assets ...

Pfizer announced in February 2025 that it was taking Beqvez (fidanacogene elaparvovec), its gene therapy for hemophilia B, ...

In 2024, the number of uninsured people in the United States rose for the first time since 2019, according to a recently ...

Pfizer and BioMarin have pulled their hemophilia gene therapies, citing low demand. To prepare for his presentation at the ...